Bioactive Wound Care Market To Reach $18.4 Billion By 2030

Bioactive Wound Care Market Growth & Trends

The global bioactive wound care market is expected to reach USD 18.4 billion by 2030 and expanding at a CAGR of 7.4% from 2024 to 2030 according to a new report by Grand View Research, Inc. The prevalence of chronic skin conditions, such as pressure ulcers, diabetic foot, and other skin-related infections is on the rise. Bioactive wound care products offer available line of treatment, which act efficiently in curing the aforementioned conditions.

Hence, with the increasing target population, the bioactive wound care market is estimated to witness lucrative growth. Rise in awareness among the patients regarding personal hygiene is augmenting the demand for these products. The raised awareness levels cause patients to seek physicians’ advice at an early stage thus enabling timely interventions.

Rising per capita healthcare expenditure in the recent years and the increasing disposable income is enabling the population to spend a substantial amount on healthcare facilities, thereby contributing towards the growth of the market. The development of advanced products, such as combination wound dressings containing multiple ingredients that offer several benefits to patients, is anticipated to boost the demand for these products.

 Request a free sample copy or view report summary: Bioactive Wound Care Market Report

Bioactive Wound Care Market Report Highlights

• Moist wound care dominated the market and accounted for a share of 61.1% in 2023. Moist wound dressings create an optimal healing environment by maintaining the right moisture level, preventing dehydration, and promoting cell migration for faster closure.

• General surgery accounted for the largest market revenue share of 68.6% in 2023. The general surgery segment is further classified into plastic, dermatological, pediatric and others applications.

• North America bioactive wound care market dominated the global bioactive wound care market with a revenue share of 42.6% in 2023, driven by the existence of a substantial number of individuals with diabetes and the quick acceptance of modern wound treatment methods.

Bioactive Wound Care Market Segmentation

Grand View Research has segmented the global bioactive wound care market on the basis of product, application, and region:

Bioactive Wound Care Product Outlook (Revenue, USD Million, 2018 - 2030)

• Moist Wound Care

  • Foam

  • Alginate

  • Film

  • Hydrocolloid

  • Hydrogel

• Antimicrobial Wound Care

  • Silver Based

  • Non-Silver Based

• Active Dressing

  • Biomaterial

  • Skin Substituents

Bioactive Wound Care Application Outlook (Revenue, USD Million, 2018 - 2030)

• General Surgery

  • Plastic

  • Dermatological

  • Pediatric

• Minimally Invasive Surgery

Bioactive Wound Care Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Bioactive Wound Care Market

• B. Braun SE

• Essity Health & Medical

• 3M

• Convatec Group PLC

• Covalon Technologies Ltd

• DermaRite Industries LLC

• Hollister Incorporated

• Integra LifeSciences Corporation

• Johnson & Johnson Services, Inc.

• Medtronic

• Monlnlycke Health Care AB

• Smith+Nephew